Connect to share and comment

U.S. OKs portable antidote for painkiller overdoses

By Susan Heavey WASHINGTON (Reuters) - U.S. regulators on Thursday approved a portable device to treat painkiller overdoses that people without medical training can use in emergency situations, a move to combat the rise of deaths from the abuse of opioids, including heroin. The Food and Drug Administration said making the cellphone-sized device with the recovery drug naloxone available for wider use could help save lives as opiod drug overdoses increase.

Rapper Trick Daddy arrested in Florida on cocaine, gun charges

MIAMI (Reuters) - Police arrested rapper Trick Daddy and charged him with cocaine and gun possession after a stakeout at his south Florida home on suspicion he was running a an indoor marijuana farm, according to a police affidavit. A report by the Broward Sheriff's Office said the rapper, whose real name is Maurice Young, was arrested on Thursday. He was also charged with driving with a suspended license.

Greater tension could do systemic harm to Russian firms-Norilsk

By Silvia Antonioli LAUSANNE, Switzerland (Reuters) - Any worsening of tension between Moscow and the West that leads to stiffer sanctions would do systemic damage to Russian companies by deterring investors and making borrowing more difficult, a Norilsk Nickel executive said. Russia's annexation of Ukraine's Crimean peninsula has marked the biggest East-West crisis since the Cold War and prompted the United States and Europe to impose sanctions.

India drugs giant rejects Novartis patent accusations

Leading Indian drug company Biocon on Friday rejected allegations by Novartis that it infringed on the Swiss pharmaceutical giant's patent for its blockbuster diabetes drug Galvus. Novartis announced Thursday it was seeking an injunction in the Delhi High Court to stop Biocon from launching a generic version of Galvus, also known as Vildagliptin. The suit against Biocon is the latest legal salvo in a campaign by global drugmakers against the nation's huge copycat drugs industry that the pharmaceutical companies say reduces incentives to produce cutting-edge medicines.

India drugs giant rejects Novartis patent accusations

Leading Indian drug company Biocon on Friday rejected allegations by Novartis that it infringed on the Swiss pharmaceutical giant's patent for its blockbuster diabetes drug Galvus. Novartis announced Thursday it was seeking an injunction in the Delhi High Court to stop Biocon from launching a generic version of Galvus, also known as Vildagliptin.

US approves handheld injector for painkiller overdose

US regulators on Thursday approved a hand-held injector device that average people could use in an emergency to revive a person suspected of overdosing on prescription painkillers. Evzio contains a single dose of the drug naloxone, and is the first injector of its kind on the market for untrained medical personnel, the US Food and Drug Administration said.

US approves handheld injector for painkiller overdose

US regulators on Thursday approved a handheld injector device that average people could use in an emergency to revive a person suspected of overdosing on prescription painkillers. Evzio contains a single dose of the drug naloxone, and is the first injector of its kind on the market for untrained medical personnel, the US Food and Drug Administration said. The United States is in the midst of a prescription opioid epidemic, with overdoses taking more lives than cocaine and heroin combined.

Exclusive: Boeing explores purchase of Mercury Systems - sources

By Nicola Leske and Mike Stone NEW YORK (Reuters) - Boeing Inc <BA.N> is considering buying Mercury Systems Inc <MRCY.O>, a supplier of digital signal and image processing systems to the aerospace and defense industry, according to two people familiar with the matter. Mercury, which has a market value of roughly $440 million, offers big data processing systems, software and services to companies including Boeing, Lockheed Martin Corp <LMT.N>, Northrop Grumman Corp <NOC.N> and Raytheon Co <RTN.N>.

U.S. OKs overdose treatment to fight spike in painkiller deaths

By Susan Heavey WASHINGTON (Reuters) - U.S. regulators on Thursday approved a painkiller overdose treatment in a portable device that will allow people without medical training to use in emergency situations, a move to combat the rise of deaths from prescription painkiller abuse and illicit drugs.

U.S. court voids $920-million DuPont award in Kevlar case

By Jonathan Stempel (Reuters) - A federal appeals court on Thursday threw out a $919.9 million jury verdict that favored DuPont Co in a case over the alleged theft of trade secrets for a fiber used to make Kevlar bulletproof vests. The 4th U.S. Circuit Court of Appeals in Richmond, Virginia voided the September 2011 verdict against Kolon Industries Inc "with reluctance" because the trial judge, U.S. District Judge Robert Payne, had improperly excluded evidence that was material to the South Korean company's defense.
Syndicate content